Security key
55279B202
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP)
CUSIP: 55279B202
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock, $0.00000002 par value
- Shares outstanding
- 29,545,622
- Total 13F shares
- 145,654
- Share change
- -48,690,862
- Total reported value
- $958,000
- Price per share
- $6.58
- Number of holders
- 1
- Value change
- -$28,712,302
- Number of sells
- 44
Report period
Q2 2023
Institutions
1
Top holders
1
MEIP full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Lite Strategy, Inc. SEC filings
Lite Strategy, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 55279B202
Recent filing periods:
Top shareholders of MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Anson Funds Management LP |
13F
|
Company |
45%
|
13,250,582
|
$3,033,058 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
26%
|
7,671,024
|
$1,755,898 | — | 31 Mar 2023 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
17%
|
5,163,456
|
$1,181,915 | — | 31 Mar 2023 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
16%
|
4,758,364
|
$1,088,000 | — | 31 Mar 2023 | |
| Boxer Capital, LLC |
13F
|
Company |
9.9%
|
2,913,091
|
$667,000 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
9.5%
|
2,804,357
|
$642,000 | — | 31 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
8.7%
|
2,576,900
|
$589,852 | — | 31 Mar 2023 | |
| Carlson Capital, L.P. |
13F
|
Company |
7.1%
|
2,100,000
|
$480,690 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
5%
|
1,463,996
|
$335,108 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
1,350,207
|
$309,062 | — | 31 Mar 2023 | |
| TLS Advisors LLC |
13F
|
Company |
3.6%
|
1,064,995
|
$244,000 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.2%
|
956,710
|
$218,991 | — | 31 Mar 2023 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
2%
|
600,000
|
$137,000 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
1.2%
|
356,455
|
$81,593 | — | 31 Mar 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.8%
|
235,773
|
$53,968 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.79%
|
233,931
|
$53,547 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.72%
|
211,551
|
$48,424 | — | 31 Mar 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.5%
|
146,400
|
$33,511 | — | 31 Mar 2023 | |
| Investmark Advisory Group LLC |
13F
|
Company |
0.46%
|
136,000
|
$31,130 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.46%
|
134,760
|
$31,000 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.45%
|
133,713
|
$30,607 | — | 31 Mar 2023 | |
| WITTENBERG INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0.24%
|
72,000
|
$16,488 | — | 31 Mar 2023 | |
| Mesirow Financial Investment Management, Inc. |
13F
|
Company |
0.17%
|
51,579
|
$11,806 | — | 31 Mar 2023 | |
| Annandale Capital, LLC |
13F
|
Company |
0.17%
|
49,856
|
$11,000 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.16%
|
48,306
|
$11,057 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
47,769
|
$10,939 | — | 31 Mar 2023 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.14%
|
40,100
|
$9,000 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.13%
|
37,190
|
$9,000 | — | 31 Mar 2023 | |
| PFG Investments, LLC |
13F
|
Company |
0.11%
|
33,500
|
$7,668 | — | 31 Mar 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.1%
|
30,717
|
$7,000 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
27,579
|
$6,288 | — | 31 Mar 2023 | |
| BROWN ADVISORY INC |
13F
|
Company |
0.08%
|
24,142
|
$5,526 | — | 31 Mar 2023 | |
| BROOKS, MOORE & ASSOCIATES, INC. |
13F
|
Company |
0.08%
|
23,685
|
$5,000 | — | 31 Mar 2023 | |
| RAYMOND JAMES & ASSOCIATES |
13F
|
Company |
0.08%
|
22,355
|
$5,117 | — | 31 Mar 2023 | |
| Cetera Advisor Networks LLC |
13F
|
Company |
0.06%
|
19,000
|
$4,349 | — | 31 Mar 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.04%
|
12,839
|
$2,939 | — | 31 Mar 2023 | |
| NFSG Corp |
13F
|
Company |
0.04%
|
11,000
|
$2,518 | — | 31 Mar 2023 | |
| HighMark Wealth Management LLC |
13F
|
Company |
0.04%
|
10,600
|
$2,426 | — | 31 Mar 2023 | |
| D.A. DAVIDSON & CO. |
13F
|
Company |
0.03%
|
10,000
|
$2,289 | — | 31 Mar 2023 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.03%
|
9,243
|
$2,116 | — | 31 Mar 2023 | |
| EVERMAY WEALTH MANAGEMENT LLC |
13F
|
Company |
0%
|
950
|
$218 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0%
|
518
|
$119 | — | 31 Mar 2023 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
500
|
$114 | — | 31 Mar 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
52
|
$12 | — | 31 Mar 2023 | |
| AdvisorNet Financial, Inc |
13F
|
Company |
0%
|
14
|
$3 | — | 31 Mar 2023 | |
| Brian G. Drazba |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
350,000
|
— | — | 05 Jul 2022 | |
| David M. Urso |
3/4/5
|
President and CEO, Director |
—
class O/S missing
|
166,571
|
— | — | 02 Jun 2023 | |
| Cheryl Cohen |
3/4/5
|
Director |
—
class O/S missing
|
87,500
|
— | — | 05 Jul 2022 | |
| Christine Anna White |
3/4/5
|
Director |
—
class O/S missing
|
87,500
|
— | — | 05 Jul 2022 | |
| Kevan Clemens |
3/4/5
|
Director |
—
class O/S missing
|
50,000
|
— | — | 01 Jul 2021 |
Institutional Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q2 2023
As of 30 Jun 2023,
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
145,654 shares.
The largest 1 holders included
Boxer Capital, LLC.
This page lists
1
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
45
Q2 2023 holders
1
Holder diff
-44
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.